LTR Pharma Ltd (ltp) Logo

LTR Pharma Ltd (LTP)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it



LTR Pharma Ltd (LTP) is a drug development, research and repurposing company, focused on men's health and, currently commercialising a rapid onset, on-demand therapeutic nasal spray for the treatment of ED.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume (4w avg)
Day Range -
Prev Close
Last Trade


1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) +341.17%


Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 1,066 of 2,384
Sector Rank 89 of 227

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies BMT / PEB / AHX
EPS -$0.01
DPS $0.00
Book Value Per Share $0.054

Broker Consensus

LTP is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.


Price Sensitive only

Corporate Overview

Corporate Details

Head Office Brisbane QLD 4000
Registry Automic
Auditor William Buck Audit (WA) Pty Ltd
Date Listed 11 Dec 2023

Upcoming Calendar (Forecasted)

Date Event
26/02/2025 Report (Interim)

Former Company Names

  • LTR Pharma Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management



Director Interests

The current holdings of LTP directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Maja McGuire 06/09/2021 N/A 235,492 500,000 N/A
Julian Chick 25/11/2020 808,492 46,373,750 500,000 N/A
Lee Rodne 07/10/2020 1,129,641 51,543,893 1,000,000 N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Dec 5, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
LTR Medical Pty Ltd 46,373,750 32.26%
Strategic Drug Solutions Inc 5,933,000 4.26%
Parkview SC Bio Llc 4,250,313 3.05%
Trexapharm Inc 4,188,000 3.00%
Go Medical Industries Pty Ltd 2,443,000 1.75%
Mr Philip John Cawood 2,320,179 1.66%
Merrill Lynch (Australia) Nominees Pty Limited 2,125,000 1.52%
Alium Capital Management Pty Ltd 1,562,500 1.12%
Wolseley Road 1 Pty Limited 1,457,500 1.05%
Mr Jason Benjamin Rich <Le 779670 M/L A/C> 1,312,500 0.94%
Fredronn Pty Ltd <Fredronn Family A/C> 1,240,625 0.89%
Tempest Dawn Pty Limited <Swt Super Fund A/C> 1,142,857 0.82%
HGL Investments Pty Ltd 1,125,000 0.81%
Danny Zanardo 1,122,135 0.80%
Mr Peter Wade <Wade Family A/C> 1,089,286 0.78%
UBS Nominees Pty Ltd 1,000,000 0.72%
LTR Consulting Pty Ltd 982,143 0.70%
Chifley Portfolios Pty Ltd ATF The David Hannon Retirement Fund 962,500 0.69%
Cityscape Asset Pty Ltd <Cityscape Family A/C> 911,000 0.65%
HSBC Custody Nominees (Australia) Limited A/C 2 875,000 0.63%
Jason Rich 875,000 0.63%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 0 0 164 290 168 622

Substantial Shareholders

No Substantial Shareholders for LTP in our database.

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
No Financial Year End data available
LTP Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.